首页> 外国专利> BENZIMIDAZOLONE COMPOUNDS WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE

BENZIMIDAZOLONE COMPOUNDS WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE

机译:在M1受体上具有活性的苯并咪唑酮化合物及其在医学中的用途

摘要

Compounds which have activity at M1 receptor and their uses in medicineCompounds of formula (I) and salts and solvates are provided: wherein R4 isfluoro, R5 is selected from hydrogen, halogen, cyano, C1-6alkyl, C1-6alkylsubstituted with one or more fluorine atoms, C1-6alkoxy, and C1-6alkoxysubstituted with one or more fluorine atoms; and R6 is selected from halogen,cyano, C1-6alkyl, C1-6alkyl substituted with one or more fluorine atoms, C3-6cycloalkyl, C3-6cycloalkyl substituted with one or more fluorine atoms, C1-6alkoxy and C1-6alkoxy substituted with one or more fluorine atoms, and Q ishydrogen or C1-6alkyl. The compounds are expected to be useful for therapy,for example in the treatment of psychotic disorders and cognitive impairment.
机译:对M1受体具有活性的化合物及其在医学中的用途提供了式(I)的化合物以及其盐和溶剂合物:其中R 4为氟,R 5选自氢,卤素,氰基,C 1-6烷基,C 1-6烷基被一个或多个氟原子,C1-6烷氧基和C1-6烷氧基取代被一个或多个氟原子取代; R6选自卤素,氰基,C1-6烷基,被一个或多个氟原子取代的C1-6烷基,C3-6环烷基,被一个或多个氟原子取代的C3-6环烷基,C1-一个或多个氟原子取代的6烷氧基和C1-6烷氧基,Q为氢或C 1-6烷基。这些化合物有望用于治疗,例如治疗精神病和认知障碍。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号